Skip to main content

Loteprednol News

FDA Approves Eysuvis (loteprednol etabonate) Ophthalmic Suspension for the Short-Term Treatment of the Signs and Symptoms of Dry Eye Disease

WATERTOWN, Mass.--(BUSINESS WIRE)--Oct. 27, 2020-- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative...

FDA Approves Inveltys (loteprednol etabonate) for Post-Operative Inflammation and Pain Following Ocular Surgery

WALTHAM, Mass.--(BUSINESS WIRE)--Aug. 23, 2018-- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of therapeutics using its...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Keratoconjunctivitis Sicca, Allergies, Rosacea

Loteprednol patient information at Drugs.com